Axogen

AXGNNasdaq United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$2.496 B

$46.43 +4.69%

Close of 7 Aug 2026

Revenue

$225.2M

#2262 by revenue

Earnings

-$15.7M

Loss-making

Shares outstanding

53,761,513

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus — ranked by market cap

All 28 →

#3LivaNovaLIVN$4.20B
#4TransMedics GroupTMDX$2.91B
#5AxogenAXGN$2.50B
#6Biolife SolutionsBLFS$1.69B
#7CONMEDCNMD$1.47B

Where these numbers come from

Share counts and financials for Axogen are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.